TrialMultiple sclerosis (Houndmills, Basingstoke, England)2021

Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis.

Robert A Bermel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.